FAVIPIRAVIR MEDITOP 200mg tablets medication leaflet

J05AX27 favipiravir • Antiinfectives for systemic use | Direct acting antivirals | Other antivirals

Favipiravir is an antiviral medication used to treat certain viral infections, especially influenza and, in some countries, COVID-19. It works by inhibiting the replication of the virus in the body, helping to reduce the severity and duration of the illness. Favipiravir is usually administered in tablet form, as prescribed by the doctor.

The dose and duration of favipiravir treatment are determined by the doctor, depending on the type of infection and the patient's overall condition. It is important for the patient to strictly follow the treatment regimen to ensure the effectiveness of the medication and to prevent the development of viral resistance.

Common side effects may include nausea, vomiting, diarrhea, increased liver transaminase levels, or a decrease in white blood cell count. In rare cases, allergic reactions or kidney function disorders may occur. Any unusual symptoms should be reported to the doctor immediately.

Favipiravir is an important option in the treatment of viral infections, but its use requires careful medical monitoring. Following the doctor's recommendations and being informed about possible side effects contribute to safe and effective treatment.

General data about FAVIPIRAVIR MEDITOP 200mg

Substance: favipiravir

Date of last drug list: 01-11-2024

Commercial code: W68164001

Concentration: 200mg

Pharmaceutical form: tablets

Quantity: 40

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: MEDITOP GYOGYSZERIPARI KFT. - UNGARIA

Holder: BIOEEL S.R.L. - ROMANIA

Number: 662/2021/01